Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

cannabichromene × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cyclophosphamide 2740 Cisplatin 2718 Carboplatin 2518 Radiotherapy 2426 Paclitaxel 2308 Gemcitabine 2170 pembrolizumab 2026 Docetaxel 1912 Bevacizumab 1867 Fluorouracil 1582 Capecitabine 1573 Oxaliplatin 1475 Dexamethasone 1359 Nivolumab 1333 Doxorubicin 1284 Rituximab 1277 Magnetic Resonance Spectroscopy 1175 Etoposide 1145 Irinotecan 1067 Leucovorin 1047 Drug Therapy 1024 Cytarabine 986 fludarabine 912 Pemetrexed 904 Specimen Handling 843 Vincristine 812 Lenalidomide 809 Cetuximab 805 Prednisone 803 Trastuzumab 802

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06533657 2026-03-12

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Active not recruiting

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡